BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schlicker E, Kathmann M. Role of the Histamine H3 Receptor in the Central Nervous System. Handb Exp Pharmacol 2017;241:277-99. [PMID: 27787717 DOI: 10.1007/164_2016_12] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Vernia F, Di Ruscio M, Ciccone A, Viscido A, Frieri G, Stefanelli G, Latella G. Sleep disorders related to nutrition and digestive diseases: a neglected clinical condition. Int J Med Sci 2021;18:593-603. [PMID: 33437194 DOI: 10.7150/ijms.45512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Phillips HN, Tormoehlen L. Toxin-Induced Seizures. Neurol Clin 2020;38:867-79. [PMID: 33040866 DOI: 10.1016/j.ncl.2020.07.004] [Reference Citation Analysis]
3 Provensi G, Costa A, Izquierdo I, Blandina P, Passani MB. Brain histamine modulates recognition memory: possible implications in major cognitive disorders. Br J Pharmacol 2020;177:539-56. [PMID: 30129226 DOI: 10.1111/bph.14478] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
4 Guevarra JT, Hiensch R, Varga AW, Rapoport DM. Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility. Nat Sci Sleep 2020;12:709-19. [PMID: 33117007 DOI: 10.2147/NSS.S264140] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zakrocka I, Swiader K, Swiader M. Influence of ketotifen and conventional antiepileptic drugs on the exploratory and spontaneous locomotor activity in mice. Current Issues in Pharmacy and Medical Sciences 2020;33:206-10. [DOI: 10.2478/cipms-2020-0039] [Reference Citation Analysis]
6 Wágner G, Mocking TAM, Kooistra AJ, Slynko I, Ábrányi-Balogh P, Keserű GM, Wijtmans M, Vischer HF, de Esch IJP, Leurs R. Covalent Inhibition of the Histamine H3 Receptor. Molecules 2019;24:E4541. [PMID: 31835873 DOI: 10.3390/molecules24244541] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mello e Souza T. Unraveling molecular and system processes for fear memory. Neuroscience 2022. [DOI: 10.1016/j.neuroscience.2022.03.015] [Reference Citation Analysis]
8 Łażewska D, Kieć-Kononowicz K. Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017). Expert Opin Ther Pat 2018;28:175-96. [PMID: 29334795 DOI: 10.1080/13543776.2018.1424135] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
9 Espinosa-bustos C, Leitzbach L, Añazco T, Silva MJ, Campo AD, Castro-alvarez A, Stark H, Salas CO. Substituted Purines as High-Affinity Histamine H3 Receptor Ligands. Pharmaceuticals 2022;15:573. [DOI: 10.3390/ph15050573] [Reference Citation Analysis]
10 Lindskog M. Histamine Receptors in the Cross-Talk between Periphery and Brain. Int J Neuropsychopharmacol 2017;20:400-2. [PMID: 28340169 DOI: 10.1093/ijnp/pyx018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
11 Shan L, Bao A, Swaab DF. Changes in Histidine Decarboxylase, Histamine N-Methyltransferase and Histamine Receptors in Neuropsychiatric Disorders. In: Hattori Y, Seifert R, editors. Histamine and Histamine Receptors in Health and Disease. Cham: Springer International Publishing; 2017. pp. 259-76. [DOI: 10.1007/164_2016_125] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
12 Schalla MA, Stengel A. Activity Based Anorexia as an Animal Model for Anorexia Nervosa-A Systematic Review. Front Nutr 2019;6:69. [PMID: 31165073 DOI: 10.3389/fnut.2019.00069] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
13 Salimi S, Tamaddonfard E. Microinjection of histamine and its H3 receptor agonist and antagonist into the agranular insular cortex influence sensory and affective components of neuropathic pain in rats. Eur J Pharmacol 2019;857:172450. [PMID: 31202805 DOI: 10.1016/j.ejphar.2019.172450] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
14 Scammell TE, Jackson AC, Franks NP, Wisden W, Dauvilliers Y. Histamine: neural circuits and new medications. Sleep 2019;42. [PMID: 30239935 DOI: 10.1093/sleep/zsy183] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
15 Sil’kis IG. A Neurochemical Approach to the Search for Drugs for the Treatment of Symptoms of Alzheimer’s Disease. Neurochem J 2018;12:15-22. [DOI: 10.1134/s1819712418010130] [Reference Citation Analysis]
16 Chai Z, Wu Z, Ji Q, Wang J, Wang J, Wang H, Zhang C, Zhong J, Xin J. Genome-Wide DNA Methylation and Hydroxymethylation Changes Revealed Epigenetic Regulation of Neuromodulation and Myelination in Yak Hypothalamus. Front Genet 2021;12:592135. [PMID: 34646294 DOI: 10.3389/fgene.2021.592135] [Reference Citation Analysis]
17 Wágner G, Mocking TAM, Arimont M, Provensi G, Rani B, Silva-Marques B, Latacz G, Da Costa Pereira D, Karatzidou C, Vischer HF, Wijtmans M, Kieć-Kononowicz K, de Esch IJP, Leurs R. 4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H3 Receptor Agonists with in Vivo Central Nervous System Activity. J Med Chem 2019;62:10848-66. [PMID: 31675226 DOI: 10.1021/acs.jmedchem.9b01462] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
18 Meskill GJ, Kallweit U, Zarycranski D, Caussé C, Finance O, Ligneau X, Davis CW. Pitolisant for the treatment of cataplexy in adults with narcolepsy. Expert Opinion on Orphan Drugs. [DOI: 10.1080/21678707.2021.2022472] [Reference Citation Analysis]
19 Bajda M, Łażewska D, Godyń J, Zaręba P, Kuder K, Hagenow S, Łątka K, Stawarska E, Stark H, Kieć-Kononowicz K, Malawska B. Search for new multi-target compounds against Alzheimer's disease among histamine H3 receptor ligands. Eur J Med Chem 2020;185:111785. [PMID: 31669851 DOI: 10.1016/j.ejmech.2019.111785] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
20 Nguyen PL, Cho J. Pathophysiological Roles of Histamine Receptors in Cancer Progression: Implications and Perspectives as Potential Molecular Targets. Biomolecules 2021;11:1232. [PMID: 34439898 DOI: 10.3390/biom11081232] [Reference Citation Analysis]
21 Phillips HN, Tormoehlen L. Toxin-Induced Seizures ∗Adapted from “Toxin-Induced Seizures” in Neurologic Clinics, November 2020. Emergency Medicine Clinics of North America 2022. [DOI: 10.1016/j.emc.2022.01.010] [Reference Citation Analysis]
22 Midzyanovskaya IS, Birioukova LM, Storvik M, Luijtelaar GV, Tuomisto LM. The prefrontal cortex shows widespread decrease in H3 histamine receptor binding densities in rats with genetic generalized epilepsies. Epilepsy Research 2022. [DOI: 10.1016/j.eplepsyres.2022.106921] [Reference Citation Analysis]
23 Krief S, Berrebi-Bertrand I, Nagmar I, Giret M, Belliard S, Perrin D, Uguen M, Robert P, Lecomte JM, Schwartz JC, Finance O, Ligneau X. Pitolisant, a wake-promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol. Pharmacol Res Perspect 2021;9:e00855. [PMID: 34423920 DOI: 10.1002/prp2.855] [Reference Citation Analysis]
24 Provensi G, Passani MB, Costa A, Izquierdo I, Blandina P. Neuronal histamine and the memory of emotionally salient events. Br J Pharmacol 2020;177:557-69. [PMID: 30110713 DOI: 10.1111/bph.14476] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
25 Bönisch H, Fink KB, Malinowska B, Molderings GJ, Schlicker E. Serotonin and beyond-a tribute to Manfred Göthert (1939-2019). Naunyn Schmiedebergs Arch Pharmacol 2021;394:1829-67. [PMID: 33991216 DOI: 10.1007/s00210-021-02083-5] [Reference Citation Analysis]
26 Eberhard KE, Kirkeby S, Hansen LJ, Cayé-thomasen P. Neurotransmitter and Neurotransmitter Receptor Expression in the Saccule of the Human Vestibular System. Progress in Neurobiology 2022. [DOI: 10.1016/j.pneurobio.2022.102238] [Reference Citation Analysis]
27 Sandiego CM, Barret O, Lee H, Alagille D, Amenta A, Fowles K, Holden D, Seibyl JP, Tamagnan G. Imaging histamine H3 receptors with [18 F]FMH3: Test-retest and occupancy studies in the non-human primate. Synapse 2019;73:e22096. [PMID: 30835877 DOI: 10.1002/syn.22096] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Obara I, Telezhkin V, Alrashdi I, Chazot PL. Histamine, histamine receptors, and neuropathic pain relief. Br J Pharmacol 2020;177:580-99. [PMID: 31046146 DOI: 10.1111/bph.14696] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 11.3] [Reference Citation Analysis]
29 Lopresti BJ, Royse SK, Mathis CA, Tollefson SA, Narendran R. Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disorders. J Neurochem 2022. [PMID: 35536762 DOI: 10.1111/jnc.15615] [Reference Citation Analysis]
30 Riddy DM, Cook AE, Shackleford DM, Pierce TL, Mocaer E, Mannoury la Cour C, Sors A, Charman WN, Summers RJ, Sexton PM, Christopoulos A, Langmead CJ. Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H3 receptor antagonists. Neuropharmacology 2019;144:244-55. [PMID: 30359639 DOI: 10.1016/j.neuropharm.2018.10.028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]